Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 451-620-7 | CAS number: 352230-22-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Developmental toxicity / teratogenicity
Administrative data
- Endpoint:
- developmental toxicity
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2004-09-14 to 2005-02-21
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- guideline study with acceptable restrictions
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 005
- Report date:
- 2005
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- other: OECD Guideline 422 (Combined Repeated Dose Toxicity Study with the Reproduction / Developmental Toxicity Screening Test)
- Deviations:
- yes
- Remarks:
- There is a discrepancy about treatment duration of females between executive summary and treatment regime paragraph. Also, the pups were killed on postnatal day 4.
- GLP compliance:
- yes
- Limit test:
- no
Test material
- Reference substance name:
- 1,3,5-trimethyl-1,1,3,5,5-pentaphenyltrisiloxane
- EC Number:
- 222-222-9
- EC Name:
- 1,3,5-trimethyl-1,1,3,5,5-pentaphenyltrisiloxane
- Cas Number:
- 3390-61-2
- Molecular formula:
- C33H34O2Si3
- IUPAC Name:
- 1,3,5-trimethyl-1,1,3,5,5-pentaphenyltrisiloxane
- Test material form:
- other: liquid
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Laboratories Inc., United States
- Age at study initiation: 7 weeks
- Weight at study initiation:
Females: 189.8 to 237.2 g
Males: 285.5 to 357.1 g
- Fasting period before study: none
- Housing: individually housed individually in suspended wire-mesh cages during quarantine and throughout the course of the study.
- Diet: Certified rodent diet, ad libitum
- Water: Municipal water, ad libitum
- Acclimation period: 6 days
ENVIRONMENTAL CONDITIONS
- Temperature (°F): 64-79°F
- Humidity (%): 30-70 %
- Air changes (per hour): 10-15/hour
- Photoperiod (hours dark / hours light): 12/12
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- corn oil
- Details on exposure:
- PREPARATION OF DOSING SOLUTIONS: Dosing solutions were prepared twice during the course of the study. Corn oil was the chosen vehicle. The test substance was weighed then enough vehicle was added to obtain the correct volume.
VEHICLE
- Justification for use and choice of vehicle (if other than water): Corn oil was the chosen vehicle in the 14-day range-finding study.
- Concentration in vehicle: no data
- Amount of vehicle (if gavage): no data
- Lot/batch no. (if required): 1st preparation 122K0131; 2nd preparation 103K0107
- Purity: As provided by the manufacturer - Analytical verification of doses or concentrations:
- yes
- Details on analytical verification of doses or concentrations:
- Dosing solutions analysis were analysed by CG/FID to verify concentration, stability and homogeneity of the test substance in the vehicle. Prior to the experiment, a high dose solution was prepared and stability testing was performed on days 0, 14, 35 and 50. Following the second preparation of dose solutions, homogeneity analysis of the low and high dose solutions was conducted on day 0 and stability analysis of the low dose solution was conducted on days 0 and 50. Concentration verification was of the dose solutions was conducted on the day of the first preparation and prior to the end of dosing.
- Details on mating procedure:
- - M/F ratio per cage: A 1:1 mating ratio was used.
- Length of cohabitation: The female animals were housed continuously with the same male until evidence of mating occurred.
- Proof of pregnancy: presence of a vaginal plug and/or sperm in vaginal smear referred to as day 0 of pregnancy
- After successful mating each pregnant female was caged: individually
- Any other deviations from standard protocol: no - Duration of treatment / exposure:
- Both males and females were treated with the test substance for 2 weeks prior to mating period and continued through the mating period. Males were treated for 92 days and females were treated up to and including postpartum day 3 according to treatment regime paragraph in the study report or up to gestation day 19 according to the execute summary in the study report.
- Frequency of treatment:
- Daily, 7 days a week
- Duration of test:
- Males: 92 days
Females: treated up to and including postpartum day 3 according to treatment regime paragraph in the study report or up to gestation day 19 according to the execute summary in the study report.
- No. of animals per sex per dose:
- 10 males and 10 females per dose
- Control animals:
- yes, concurrent no treatment
- Details on study design:
- - Dose selection rationale: Dose levels were determined based on the results of a 14-day range-finding study. Doses were administered at a volume of 2 mL/kg of body weighed. The administered volumes were based on the weekly scheduled body weights.
Examinations
- Maternal examinations:
- CAGE SIDE OBSERVATIONS: Yes
- Time schedule: Prior to the start of treatment and during the 12th week of the study
- Cage side observations included: abnormal muscle movements, abnormal behaviour, posture and resistance to removal
DETAILED CLINICAL OBSERVATIONS: Yes
- Time schedule: General clinical observations were made once a day throughout the treatment period. All animals received detailed physical observations once before the start of the treatment and weekly thereafter.
BODY WEIGHT: Yes
- Time schedule for examinations: Individual body weights were determined prior to the treatment, on the first day of dosing, then weekly and on the day of necropsy. During gestation females were weighed on gestation days 0, 7, 14 and 20, within 24 hours after parturition, and on day 4 postpartum.
POST-MORTEM EXAMINATIONS: Yes
- Sacrifice on gestation day # Females were euthanized on postpartum day 4. Mated females that did not deliver were euthanized on gestation days 25 or 26.
- Organs examined: For pregnant females, the number of corpora lutea and the number of implantation sites were recorded. For the females that failed to produce litter the uteri were examined to determine possible reabsorbed implant sites.
OTHER:
FOOD CONSUMPTION: Yes
- Time schedule for examination: Individual male animals' food consumption was recorded on the first day of dosing, weekly thereafter until the day of necropsy with an exception of the two week mating period. Female animals' food consumption was recorded on days 1, 8, 15, and on gestation days 0, 7, 14 and 20, and on day 4 postpartum. - Ovaries and uterine content:
- The ovaries and uterine content was examined after termination: Yes
Examinations included:
- Gravid uterus weight: Yes
- Number of corpora lutea: Yes
- Number of implantations: Yes
- Number of resorptions: Yes - Fetal examinations:
- - External examinations: Yes: all per litter
- Soft tissue examinations: No
- Skeletal examinations: No
- Head examinations: Yes - Statistics:
- - ANCOVA was used to analyse Reproductive Parameters.
- ANOVA was used to analyse litter size. - Indices:
- The evaluated indices were: mean litter size, mean live litter size, mean litter weight, mean ratio live births/litter size
Results and discussion
Results: maternal animals
Maternal developmental toxicity
- Details on maternal toxic effects:
- Maternal toxic effects:no effects
Details on maternal toxic effects:
No treatment-related toxic effect was noted in female animals.
Effect levels (maternal animals)
- Key result
- Dose descriptor:
- NOAEL
- Effect level:
- >= 1 000 mg/kg bw/day (actual dose received)
- Based on:
- test mat.
- Basis for effect level:
- other: No adverse effects observed
Maternal abnormalities
- Key result
- Abnormalities:
- no effects observed
Results (fetuses)
- Details on embryotoxic / teratogenic effects:
- Embryotoxic / teratogenic effects:no effects
Details on embryotoxic / teratogenic effects:
No treatment-related toxic effect was noted in pups.
Effect levels (fetuses)
- Key result
- Dose descriptor:
- NOAEL
- Effect level:
- >= 1 000 mg/kg bw/day (actual dose received)
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- other: No adverse effects observed
Fetal abnormalities
- Key result
- Abnormalities:
- no effects observed
Overall developmental toxicity
- Key result
- Developmental effects observed:
- no
Any other information on results incl. tables
Table 1: Mean reproductive parameters for reproductive group female rats
|
|
Litter |
Initial |
Final |
|
|
|||||||
|
Days gestation |
Male pups |
Female pups |
Males/females |
Total pups |
Day 4 viable pups |
Viable/ total |
Litter weight (g) |
Average pup weight (g) |
Litter weight (g) |
Average pup weight (g) |
Total implants |
Corpora lutea |
Group 1 |
|
||||||||||||
Mean |
22 |
8.4 |
7.9 |
1.1 |
16.3 |
15.4 |
0.9 |
108.9 |
6.7 |
160.5 |
10.5 |
17.0 |
22.6 |
N |
7A |
7 |
7 |
7 |
7 |
7 |
7 |
7 |
7 |
7 |
7 |
7 |
7 |
Group 2 |
|
||||||||||||
Mean |
21.9 |
7.0 |
8.1 |
0.9 |
15.1 |
14.7 |
1.0 |
95.6 |
6.3 |
150.2 |
10.3 |
16.6 |
21.3 |
N |
9A |
9 |
9 |
9 |
9 |
9 |
9 |
9 |
|
9 |
9 |
9 |
9 |
Group 3 |
|
||||||||||||
Mean |
21.7 |
6.1 |
9.6 |
0.7 |
15.7 |
15.3 |
1.0 |
99.9 |
6.4 |
152.7 |
10.0 |
16.4 |
18.0 |
N |
7A |
7 |
7 |
7 |
7 |
7 |
7 |
7 |
7 |
7 |
7 |
7 |
7 |
Group 4 |
|
||||||||||||
Mean |
21.8 |
6.9 |
8.8 |
0.9 |
15.7 |
15.1 |
1.0 |
98.9 |
6.3 |
147.2 |
9.8 |
16.6 |
20.9 |
N |
9B |
9 |
9 |
9 |
9 |
9 |
9 |
9 |
9 |
9 |
9 |
9 |
9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
A: data of non-pregnant females with positive evidence of mating not included in calculations
B: data of female that failed to deliver not included in calculations
Table 2: Summary of reproductive performance for reproductive group female rats
|
Group 1 (control) |
Group 2 (200 mg/kg bw/day) |
Group 3 (500 mg/kg bw/day) |
Group 4 (1000 mg/kg bw/day) |
Females on study |
10 |
10 |
10 |
10 |
Females that died during study |
0 |
0 |
0 |
0 |
Females euthanized in extremis |
0 |
0 |
0 |
0 |
Females allowed to deliver |
10 |
10 |
10 |
10 |
Nongravid |
3 |
1 |
3 |
0 |
Gravid |
7 |
9 |
7 |
10 |
Females with evidence of copulation |
10 |
10 |
10 |
10 |
Number which delivered |
7 |
9 |
7 |
9 |
Number which did not deliver |
3 |
1 |
3 |
1 |
Females with no evidence of copulation |
0 |
0 |
0 |
0 |
Number which delivered |
0 |
0 |
0 |
0 |
Number which did not deliver |
0 |
0 |
0 |
0 |
Applicant's summary and conclusion
- Conclusions:
- In a Combined Repeated Dose Toxicity Study with the Reproduction / Developmental Toxicity Screening Test in rats for 1,3,5-trimethyl-1,1,3,5,5-pentaphenyltrisiloxane , the reported NOAEL value for maternal and developmental toxicity was >= 1000 mg/kg/day.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.